KU Leuven RDR Dataverse OAI Archive
metadata only
CC BY-SA 4.0
Replication Data for: GLP1-E2 Therapy Delays Autoimmune Diabetes in Late-stage Prediabetic NOD Mice and Potentiates Low-dose Anti-CD3 Therapy for Enhanced Disease Protection
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- GLP1-E2 therapy delays autoimmune diabetes in late-stage prediabetic NOD mice and potentiates low-dose anti-CD3 therapy for enhanced disease protection#319403
- GLP-1R-GIPR-PPARα/γ/δ quintuple agonism corrects obesity and diabetes in mice.#218994
- The Role of Regulatory T Cell in Patients With Type 1 Diabetes Mellitus#238284
- Beta Cell Function in (Pre) Type 1 Diabetes#405282
- Adherence to GLP-1 receptor agonists and SGLT2 inhibitors by out-of-pocket spending among Medicare beneficiaries with diabetes.#375570
Record · ID 231862
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive